Cover Image
市場調查報告書

自體免疫性肝炎:全球臨床實驗趨勢

Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 332925
出版日期 內容資訊 英文 61 Pages
訂單完成後即時交付
價格
Back to Top
自體免疫性肝炎:全球臨床實驗趨勢 Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015
出版日期: 2015年04月30日 內容資訊: 英文 61 Pages
簡介

本報告提供自體免疫性肝炎相關臨床研究的最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,受驗者採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 自體免疫性肝炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上自體免疫性肝炎的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:腸胃疾病治療藥臨床實驗上自體免疫性肝炎的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

自體免疫性肝炎治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Veloxis Pharmaceuticals A/S
    • Iltoo Pharma
    • Dr. Falk Pharma GmbH
    • BioIncept, LLC
    • Alfact Innovation
  • 有代表性的研究機關·醫院臨床實驗概要
    • Beijing 302 Hospital
    • 順天堂大學醫學系
    • Mayo Clinic
    • Rigshospitalet
    • Tehran University of Medical Sciences
    • The National Institute of Allergy and Infectious Diseases
    • University of Sao Paulo General Hospital

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2670CTIDB

GlobalData's clinical trial report, "Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015" provides data on the Autoimmune Hepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Autoimmune Hepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Autoimmune Hepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Autoimmune Hepatitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Autoimmune Hepatitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Autoimmune Hepatitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Veloxis Pharmaceuticals A/S
      • Clinical Trial Overview of Veloxis Pharmaceuticals A/S
      • Iltoo Pharma
      • Clinical Trial Overview of Iltoo Pharma
      • Dr. Falk Pharma GmbH
      • Clinical Trial Overview of Dr. Falk Pharma GmbH
      • BioIncept, LLC
      • Clinical Trial Overview of BioIncept, LLC
      • Alfact Innovation
      • Clinical Trial Overview of Alfact Innovation
    • Clinical Trial Overview of Top Institutes / Government
      • Beijing 302 Hospital
      • Clinical Trial Overview of Beijing 302 Hospital
      • Juntendo University School of Medicine
      • Clinical Trial Overview of Juntendo University School of Medicine
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • University of Sao Paulo General Hospital
      • Clinical Trial Overview of University of Sao Paulo General Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Autoimmune Hepatitis Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Autoimmune Hepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Veloxis Pharmaceuticals A/S, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Iltoo Pharma, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Falk Pharma GmbH, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by BioIncept, LLC, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfact Innovation, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing 302 Hospital, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo General Hospital, 2015*

List of Figures

  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Europe, Top Countries (%), 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*
  • Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Autoimmune Hepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top